M
Matthew Koshy
Researcher at University of Chicago
Publications - 125
Citations - 4140
Matthew Koshy is an academic researcher from University of Chicago. The author has contributed to research in topics: Cancer & Hazard ratio. The author has an hindex of 32, co-authored 117 publications receiving 3305 citations. Previous affiliations of Matthew Koshy include Cornell University & Baylor College of Medicine.
Papers
More filters
Journal ArticleDOI
Age, gender, and racial differences in incidence and survival in primary CNS lymphoma
John L. Villano,Matthew Koshy,Matthew Koshy,H. Shaikh,Therese A. Dolecek,Bridget J. McCarthy +5 more
TL;DR: There is an increase in incidence of PCNSL in the elderly, and elderly blacks have lower incidence compared with white population, and survival remains poor and is negatively dominated by factors associated with HIV infection and advanced age.
Journal ArticleDOI
Improved survival time trends for glioblastoma using the SEER 17 population-based registries
Matthew Koshy,Matthew Koshy,John L. Villano,Therese A. Dolecek,Andrew Howard,Andrew Howard,Usama Mahmood,Steven J. Chmura,Ralph R. Weichselbaum,Ralph R. Weichselbaum,Bridget J. McCarthy +10 more
TL;DR: Encouraging results are suggested and suggest that the current treatment of glioblastoma nationwide is now associated with an improved survival compared to previous time cohorts.
Journal ArticleDOI
Disparities in Stage at Diagnosis, Treatment, and Survival in Nonelderly Adult Patients With Cancer According to Insurance Status
Gary V. Walker,Stephen R. Grant,B. Ashleigh Guadagnolo,Karen E. Hoffman,Benjamin Smith,Matthew Koshy,Pamela K. Allen,Usama Mahmood +7 more
TL;DR: Among patients with the 10 most deadly cancers, those with Medicaid coverage or without insurance were more likely to present with advanced disease, were less likely to receive cancer-directed surgery and/or radiation therapy, and experienced worse survival.
Journal ArticleDOI
Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer
Chad G. Rusthoven,Bernard L. Jones,Thomas W. Flaig,E. David Crawford,Matthew Koshy,Matthew Koshy,David J. Sher,Usama Mahmood,Ronald C. Chen,Brian F. Chapin,Brian D. Kavanagh,Thomas J. Pugh +11 more
TL;DR: In this large contemporary analysis, men with mPCa receiving prostate RT and ADT lived substantially longer than men treated withADT alone, whereas both therapies were superior to ADT alone.
Journal ArticleDOI
Increasing National Mastectomy Rates for the Treatment of Early Stage Breast Cancer
Usama Mahmood,Alexandra L. Hanlon,Matthew Koshy,R. Buras,Saranya Chumsri,K. Tkaczuk,Sally B. Cheston,William F. Regine,Steven J. Feigenberg +8 more
TL;DR: There is evidence of a reversal in the previously declining national mastectomy rates, with the mastectomy rate reaching a nadir in 2005 and subsequently rising, and women diagnosed in 2008 were more likely to undergo mastectomy.